Coronavirus vaccine: Lancet study suggests Sinovac candidate is safe and effective in phase I and II trials
Myupchar • 4 years ago CoronaVac is an inactivated vaccine (vaccine that contains a virus unable to cause disease) that had earlier shown positive results in mice, primates and rats by producing neutralising antibodies against SARS-CoV-2
